Autoimmune Diseases, Rheumatologic Disease
Conditions
Keywords
COVID-19 vaccination, Rheumatic Diseases
Brief summary
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Detailed description
Black and Latinx persons are at higher risk for certain autoimmune and inflammatory rheumatic diseases (AIRD) and have experienced worse COVID-19 outcomes compared to their white counterparts. Given the risks of severe COVID-19 outcomes such as hospitalization and death in people with AIRD, COVID-19 vaccine is recommended in this population. Historically, overall vaccine uptake among people with AIRDs has been low, and this vaccine reluctance has extended to COVID-19 vaccination. While additional COVID-19 vaccine doses have offered considerable added protection against severe outcomes, only 20% of all vaccinated persons in Alabama (AL) and 45% in Massachusetts have obtained an additional dose of COVID-19 vaccine as of October 2022. Racial and ethnic minority groups have faced disparities in obtaining subsequent COVID-19 vaccines, particularly in under-resourced communities, including those in Alabama and Massachusetts. Together, these obstacles exacerbate existing health inequities among people of color and perpetuate worse COVID-19 outcomes. We will conduct a randomized controlled study to test an intervention that seeks to address gaps in COVID-19 vaccine information and access inequities common in Black and Latinx populations.
Interventions
BEHAVIORALVideo comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
Participants will watch video focused on the importance of receipt of updated COVID-19 vaccination in patients with AIRD
BEHAVIORALVideo on the importance of good oral health for patients with AIRD
Participants will watch video on the importance of good oral health in AIRD patients.
BEHAVIORALBrochure on COVID-19 vaccination in AIRD patients
Participants
BEHAVIORALPatient Navigation
Participants will receive phone calls from patient navigators to provide support and information for receipt of updated COVID-19 vaccination in patients with AIRD
BEHAVIORALBrochure on the importance of good oral health in AIRD patients
Participants will receive a brochure on the importance of good oral health in AIRD patients.
Sponsors
University of Alabama at Birmingham
National Institute on Minority Health and Health Disparities (NIMHD)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Caregiver, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults (18+ years) with known AIRD * Black race and/or Latinx ethnicity * Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
Exclusion criteria
-Lack of access to phone
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Receipt of updated COVID-19 vaccination. | 3 months | We will measure rates of receipt of updated COVID-19 vaccination. |
Countries
United States
Contacts
CONTACTMary A Wilkenson, Clinical Research Coordinator, BS
CONTACTPaolo Rusconi, Project Director, PhD
PRINCIPAL_INVESTIGATORMaria I Danila, MD, MSc, MSPH
University of Alabama at Birmingham
Outcome results
None listed